Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by skier59on Aug 25, 2022 10:23am
151 Views
Post# 34919636

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lawsuit scam

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lawsuit scam Sometimes your comments SF are purely illogical. My point was, if an entity is doing a "Best Efforts" financing, you don't blab it into the market, especially when you are leaving it open to Retail Shareholders. How many on the "President's List" were advised prior to the announcement? Geez it's an easy score to unload 100,000's shares and reload at much lower prices, and having free trading warrants kicked in !

In regards to your final comment, how the heck am I suppose to predict what the results will be, I certainly don't have any insider knowledge ! I sure hope the results are good.

Like I said, Roger should drop this whole mess before it gets really ugly, and ends up costing Shareholders a ton of money in legal fees.



ScienceFirst wrote: Skier59 ... I think your ego is touched.  And your reaction is to blame the others.  A bit like your friend Bungee.  He was a specialist on that.

I share what I found on the public arena.  Have no link whatsoever with TLT.  Funny that you can't even understand that basic and simple concept.  And that you're too lazy to do a minimum of digging and share it with others, because these boards are all about this; sharing information that gives us more perspectives regarding our investment.

As for the 2019 pp, again, it's only your opinion that it could have been done at much better conditions because you simply don't provide any other facts that would prove you right.  So keep playing the armchair quarterback behind your keyboard, just like Bungee did.

As for you being sued, then that's your problem.  Not ours.  It's always like that with those that get sued.   They hide behind freedom of speech, thinking they can say anything, hide behind "I was only protecting shareholders", etc ....  

If you missed your entry point, than be it.  Assume yourself.  And if you incited others to join, at a poor timing, then assume yoruself.  You'd be doing high fives if you had them invested after that "disastrous" pp.  At least, they had a chance to add more at 0.16$, 0.20$, 0.25$.  Did they, considering that they invested because they believed in the science?

One last thing, you playing the armchair quarterback;  Tell us what will precisely look like the upcoming clinical data?  Then, we'll judge you on your call, after the fact.


<< Previous
Bullboard Posts
Next >>